The mean ACE2/GAPDH ratio value for 13 patients with Alzheimer’s disease was 1.22 ± 0.2, while those of five control subjects were highly consistent with a mean of 0.26 ± 0.04. Here, ACE2 is linked to Alzheimer disease.